BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34638912)

  • 21. Incidence and characteristics of thick second primary melanomas: a study of the German Central Malignant Melanoma Registry.
    Gassenmaier M; Stec T; Keim U; Leiter U; Eigentler TK; Metzler G; Garbe C
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):63-70. PubMed ID: 30051517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRAF3IP2 mediates TWEAK/TWEAKR-induced pro-fibrotic responses in cultured cardiac fibroblasts and the heart.
    Das NA; Carpenter AJ; Yoshida T; Kumar SA; Gautam S; Mostany R; Izadpanah R; Kumar A; Mummidi S; Siebenlist U; Chandrasekar B
    J Mol Cell Cardiol; 2018 Aug; 121():107-123. PubMed ID: 29981796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor-like weak inducer of apoptosis induces inflammation in Graves' orbital fibroblasts.
    Lee SJ; Kim J; Ko J; Lee EJ; Koh HJ; Yoon JS
    PLoS One; 2018; 13(12):e0209583. PubMed ID: 30576385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell cycle gene networks are associated with melanoma prognosis.
    Wang L; Hurley DG; Watkins W; Araki H; Tamada Y; Muthukaruppan A; Ranjard L; Derkac E; Imoto S; Miyano S; Crampin EJ; Print CG
    PLoS One; 2012; 7(4):e34247. PubMed ID: 22536322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases.
    Guitart J; Lowe L; Piepkorn M; Prieto VG; Rabkin MS; Ronan SG; Shea CR; Tron VA; White W; Barnhill RL
    Arch Dermatol; 2002 May; 138(5):603-8. PubMed ID: 12020220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma.
    Humbert L; Ghozlan M; Canaff L; Tian J; Lebrun JJ
    BMC Cancer; 2015 Mar; 15():200. PubMed ID: 25885043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors predicting survival in thick melanoma: Do all thick melanomas have the same prognosis?
    Han D; Han G; Morrison S; Leong SP; Kashani-Sabet M; Vetto J; White R; Schneebaum S; Pockaj B; Mozzillo N; Sondak VK; Zager JS
    Surgery; 2020 Sep; 168(3):518-526. PubMed ID: 32669204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of p53 over-expression in thin melanomas.
    Sparrow LE; English DR; Heenan PJ; Dawkins HJ; Taran J
    Melanoma Res; 1995 Dec; 5(6):387-92. PubMed ID: 8589612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test.
    Hsueh EC; DeBloom JR; Lee J; Sussman JJ; Covington KR; Middlebrook B; Johnson C; Cook RW; Slingluff CL; McMasters KM
    J Hematol Oncol; 2017 Aug; 10(1):152. PubMed ID: 28851416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metastatic microenvironment: Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells.
    Klein A; Sagi-Assif O; Izraely S; Meshel T; Pasmanik-Chor M; Nahmias C; Couraud PO; Erez N; Hoon DS; Witz IP
    Int J Cancer; 2012 Dec; 131(11):2509-18. PubMed ID: 22447293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
    Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P
    BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of chromosomal aberration (1, 3, and 8) and association of microRNAs in uveal melanoma.
    Radhakrishnan A; Badhrinarayanan N; Biswas J; Krishnakumar S
    Mol Vis; 2009 Oct; 15():2146-54. PubMed ID: 19898689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significantly high lymphatic vessel density in cutaneous metastasizing melanoma.
    Špirić Z; Erić M; Eri Ž; Skrobić M
    Hippokratia; 2015; 19(3):210-5. PubMed ID: 27418778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis.
    Izraely S; Sagi-Assif O; Klein A; Meshel T; Tsarfaty G; Pasmanik-Chor M; Nahmias C; Couraud PO; Ateh E; Bryant JL; Hoon DS; Witz IP
    Int J Cancer; 2012 Sep; 131(5):1071-82. PubMed ID: 22025079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding.
    Feltham R; Moulin M; Vince JE; Mace PD; Wong WW; Anderton H; Day CL; Vaux DL; Silke J
    J Biol Chem; 2010 Jun; 285(23):17525-36. PubMed ID: 20356846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BET inhibitor suppresses melanoma progression
    Deng G; Zeng F; Su J; Zhao S; Hu R; Zhu W; Hu S; Chen X; Yin M
    Theranostics; 2020; 10(25):11428-11443. PubMed ID: 33052224
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental atopic dermatitis is dependent on the TWEAK/Fn14 signaling pathway.
    Liu Q; Wang H; Wang X; Lu M; Tan X; Peng L; Tan F; Xiao T; Xiao S; Xia Y
    Clin Exp Immunol; 2020 Jan; 199(1):56-67. PubMed ID: 31515807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.
    Tembe V; Schramm SJ; Stark MS; Patrick E; Jayaswal V; Tang YH; Barbour A; Hayward NK; Thompson JF; Scolyer RA; Yang YH; Mann GJ
    Pigment Cell Melanoma Res; 2015 May; 28(3):254-66. PubMed ID: 25490969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis.
    Zhang G; Cheng Y; Chen G; Tang Y; Ardekani G; Rotte A; Martinka M; McElwee K; Xu X; Wang Q; Zhou Y
    Oncotarget; 2015 Sep; 6(26):23026-35. PubMed ID: 26246476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma.
    Lee DA; Cohen JA; Twaddell WS; Palacios G; Gill M; Levit E; Halperin AJ; Mones J; Busam KJ; Silvers DN; Celebi JT
    Cancer; 2006 Feb; 106(4):907-13. PubMed ID: 16421887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.